
Novan NOVN
Quarterly report 2023-Q1
added 05-15-2023
Novan P/S Ratio 2011-2026 | NOVN
Annual P/S Ratio Novan
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.11 | 21.1 | 22.9 | 3.09 | 5.73 | 26.1 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.1 | 1.11 | 13.3 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Verastem
VSTM
|
13.1 | $ 5.04 | -4.73 % | $ 349 M | ||
|
VistaGen Therapeutics
VTGN
|
151 | $ 0.57 | -5.87 % | $ 17.6 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
8.96 | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
Xenon Pharmaceuticals
XENE
|
260 | $ 54.48 | -1.89 % | $ 4.24 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Summit Therapeutics
SMMT
|
406 | $ 16.58 | -3.94 % | $ 12.4 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 317.36 | -3.29 % | $ 41.6 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
60.1 | $ 4.29 | -3.6 % | $ 822 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Fusion Pharmaceuticals
FUSN
|
669 | - | - | $ 1.41 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 19.01 | -2.66 % | $ 889 M | ||
|
Gritstone Oncology
GRTS
|
16.9 | - | 0.42 % | $ 213 M | ||
|
Завод ДИОД
DIOD
|
1.28 | - | - | - | ||
|
Фармсинтез
LIFE
|
5.39 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 20.75 | -3.35 % | $ 3.44 B | ||
|
Aligos Therapeutics
ALGS
|
30.2 | $ 6.66 | -5.4 % | $ 65.8 M | ||
|
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | ||
|
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Alkermes plc
ALKS
|
3.48 | $ 29.39 | -1.77 % | $ 4.84 B | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 2.68 | -4.96 % | $ 269 M | ||
|
AbbVie
ABBV
|
24.1 | $ 209.4 | -0.81 % | $ 370 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.27 | -2.39 % | $ 977 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M |